Adents raises €12m from Omnes, Naxicap, Caphorn

This latest funding round brings the total amount raised by Adents to €25m, of which €20m was secured over the last 18 months. All three investors had already taken part in a €8.5m expansion round back in June 2015. The company's management remains invested in the group.

The fresh capital should help Adents accelerate its international rollout and develop partnerships abroad, with a particular focus on the US, the Middle East and Asia.

The company had announced a strategic collaboration with Siemens earlier this year. Future partners for the group will mainly include System Integrators & Technology Partners.

Previous funding
In June 2015, Naxicap, Caphorn and Omnes took part in a €8.5m funding round alongside company management. Naxicap led the round with a €3.5m contribution, followed by €2m from management, while Omnes and CapHorn each deployed €1.5m. Adents intended to use the fresh capital to finance expansion across the European and North American markets, following the opening of subsidiaries Adents Canada and Adents US.

Prior to that, Naxicap had injected €1m into the company via its €8.4m BP Creation fund in February 2011, while Caphorn had added €2m in May 2013.

Company
Founded in 2007, Adents is a software developer that specialises in product indentification, traceability and serialisation. Although the company works with clients from the agri-food, wine, cosmetics and manufacturing sectors, its focus is on the pharmaceutical industry. The company operates throughout Europe, Canada and the US.

Headquartered in Massy, the business generated €2m in revenues in 2015, according to unquote data".

People
Omnes Capital – Michel de Lempdes (managing director); Marine Huber (associate).
Adents – Christophe Devins (CEO); Stephanie Fay (general manager).

Advisers
Company – Bryan Garnier & Co (corporate finance).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• France
• Technology
• France
• Naxicap
• Omnes Capital